Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Phase1: . Health care workers or the general public . Willing for nasal spray treatment Phase2: Asymptomatic or mild COVID case with a Positive nasopharyngeal swab for SARS-Cov-2 (RT-PCR) not more than two weeks
Exclusion criteria
Exclusion criteria: Phase1: Any symptoms suggestive of SARS-Cov-2 Phase2: . Nasal spray administered less than 12 hours before the study . active treatment with medications with a known side effect of dry mouth . current or prior mucosal head and neck cancer treatment, . acute or chronic upper aerodigestive tract infection,
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Exhaled bioaerosol count (particles per liter of air)Timepoint: Exhaled bioaerosol count (particles per liter of air)@ 15,30,45 minutes and 1Hr | — |
Secondary
| Measure | Time frame |
|---|---|
| Nasal irritationTimepoint: Nasal irritation @ 15,30,45 minutes and 1Hr | — |
Countries
India
Contacts
Bangalore Baptist Hospital